Rem3dy Health, a Midlands-founded health-tech company, has raised £1.4 million in new funding led by the Amsterdam-based Borski Fund and Future Planet Capital Regional. The investment strengthens the company’s global expansion plans and fuels innovation in its personalised nutrition brand, Nourished.
The funding announcement took center stage at Birmingham Tech Week’s Scale-Up Summit, shining a spotlight on the Midlands as an emerging hub for global venture investment. The event, hosted by The Lifted Project, a Treasury-backed initiative from the Rose Review, was designed to accelerate capital access for female-founded, high-growth startups across the UK.
During the summit, Melissa Snover, founder and CEO of Rem3dy Health, shared that Borski Fund contributed £900,000, while Future Planet Capital Regional added £500,000. Together, the two funds are backing Rem3dy’s vision to transform health and wellness through advanced, data-driven nutrition solutions.
Rem3dy Health’s flagship brand, Nourished, offers 3D-printed, stackable nutrition gummies tailored to individual needs. Each gummy combines multiple active ingredients into a single, personalised dose, representing a major leap forward in preventative healthcare.
The company’s patented 3D printing technology allows users to customise their supplements based on lifestyle, goals, and deficiencies. This innovation helps bridge the gap between healthcare and consumer wellness by offering truly individualised nutrition, something traditional supplement manufacturing cannot easily achieve.
The new £1.4M investment will support international market expansion, further R&D, and new product development within Nourished’s growing portfolio.
Rem3dy’s success story marks another milestone in the Midlands’ transformation into a thriving innovation hub. Despite long-standing challenges in attracting late-stage funding outside London, the region is seeing renewed momentum.
Recent initiatives such as the Inclusive Innovation Catalyst, a £30 million venture studio, and the West Midlands Co-Investment Fund have begun narrowing the regional funding gap. These programs aim to support high-potential startups and give them access to the capital they need to scale globally.
Yet, many founders still face barriers to securing growth capital once they move beyond seed stage. Rem3dy’s funding round shows that female-led startups in the Midlands can now attract top-tier global investors, provided there’s strong local ecosystem support.
This investment isn’t just about capital, it highlights how international partnerships can unlock new opportunities for regional innovators. The collaboration between Borski Fund, a European gender-lens investor, and Future Planet Capital Regional, which manages regional co-investment initiatives, represents a model for inclusive, cross-border venture growth.
Together, these investors bring far more than money to the table: they add strategic guidance, mentoring, and market access that help founders compete on a global stage.
Melissa Snover emphasised that this milestone demonstrates how world-class innovation can scale from any UK region. She noted that both investors share her belief that innovation should not be limited to London’s borders.
The £1.4M round will allow Rem3dy Health to deepen its technological edge while expanding distribution into new international markets. For the Midlands, this represents more than another funding headline, it’s a signal of growing confidence in the region’s innovation ecosystem.
As venture capital increasingly favours purpose-driven, inclusive growth, Rem3dy Health’s rise underlines a shift in how investors perceive regional and female-led startups. The company’s trajectory could well position Birmingham as one of the UK’s leading health-tech powerhouses.
Jen Roberts-Woods, Investment Associate at Borski Fund, said the firm is proud to back Rem3dy Health on its global journey. She described Melissa Snover’s vision as a clear example of what ambitious, female founders can achieve when supported by the right network and resources.
She added that the partnership with Future Planet Capital highlights how international collaboration can amplify impact, helping shape the future of personalised health innovations.
Rupert Lyle, representing Future Planet Capital Regional, echoed this sentiment. He explained that through the West Midlands Co-Investment Fund, the firm is demonstrating how regional ecosystems can become launchpads for world-class innovation.
He noted that Rem3dy Health’s success shows what’s possible when local and global capital combine, producing outcomes that are both commercially rewarding and socially transformative.
Since its founding, Rem3dy Health has raised over £20 million to pioneer its unique approach to personalised nutrition. The company continues to lead the charge in merging technology, healthcare, and consumer experience, an intersection that’s driving the next wave of health innovation.
As global interest grows in preventative health, Rem3dy’s ability to tailor nutrition through data and 3D printing places it at the forefront of this transformation. Its continued success also highlights how female-led ventures are driving impact in fields traditionally dominated by male-led companies.
For the UK startup ecosystem, this deal reinforces a crucial message: innovation thrives where diversity and inclusion are actively championed.
